Clinical Characteristics of Resistant vs. Refractory Hypertension in a Population of Hypertensive Afrodescendants
作者： Cristiano Macedo , Roque Aras , Isabella Sales de Macedo
关键词:
摘要: Resumo Fundamentos Afrodescendentes tem sido associados a uma maior gravidade da hipertensao arterial e incidencia de complicacoes cardiovasculares. Caracteristicas na apresentacao resistente (HR) ou refrataria (HRf), especificamente nessa etnia, nao devidamente estudadas. Objetivos O estudo compara caracteristicas clinicas epidemiologicas prevalencia eventos cardiovasculares em afrodescendentes com diagnostico HR HRf. Metodos: Estudo transversal realizado ambulatorio referencia para pacientes Hipertensao Grave. nivel significância foi 5%. [...]
abccardiol.org
sci-hub.st 参考文章(38)
First Brazilian position on resistant hypertension. Arquivos Brasileiros De Cardiologia. ,vol. 99, pp. 576- 585 ,(2012) , 10.1590/S0066-782X2012000700002
Donald W. Cockcroft, Henry Gault, Prediction of Creatinine Clearance from Serum Creatinine Nephron. ,vol. 16, pp. 31- 41 ,(1976) , 10.1159/000180580
Suzanne Oparil, David A. Calhoun, Maria Czarina Acelajado, Roberto Pisoni, Tanja Dudenbostel, Louis J. Dell’Italia, Falynn Cartmill, Bin Zhang, Stacey S. Cofield, Refractory Hypertension: Definition, Prevalence, and Patient Characteristics Journal of Clinical Hypertension. ,vol. 14, pp. 7- 12 ,(2012) , 10.1111/J.1751-7176.2011.00556.X
Brown MJ Williams B, MacDonald TM, Morant S, Webb DJ, Sever P, McInnes G, Ford I, Cruickshank JK, Caulfield MJ, Salsbury J, Mackenzie I, Padmanabhan S, British Hypertension Society's PATHWAY Studies Group, None, Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial The Lancet. ,vol. 386, pp. 2059- 2068 ,(2015) , 10.1016/S0140-6736(15)00257-3
Donald E. Morisky, Alfonso Ang, Marie Krousel-Wood, Harry J. Ward, Predictive validity of a medication adherence measure in an outpatient setting Journal of Clinical Hypertension. ,vol. 10, pp. 348- 354 ,(2008) , 10.1111/J.1751-7176.2008.07572.X
E Judd, D A Calhoun, Apparent and true resistant hypertension: definition, prevalence and outcomes Journal of Human Hypertension. ,vol. 28, pp. 463- 468 ,(2014) , 10.1038/JHH.2013.140
Brent M. Egan, Yumin Zhao, R. Neal Axon, Walter A. Brzezinski, Keith C. Ferdinand, Uncontrolled and Apparent Treatment Resistant Hypertension in the United States, 1988 to 2008 Circulation. ,vol. 124, pp. 1046- 1058 ,(2011) , 10.1161/CIRCULATIONAHA.111.030189
Paulo A. Lotufo, Alexandre C. Pereira, Paulo S. Vasconcellos, Itamar S. Santos, Jose Geraldo Mill, Isabela M. Bensenor, Resistant Hypertension: Risk Factors, Subclinical Atherosclerosis, and Comorbidities Among Adults—The Brazilian Longitudinal Study of Adult Health (ELSA‐Brasil) Journal of Clinical Hypertension. ,vol. 17, pp. 74- 80 ,(2015) , 10.1111/JCH.12433
Alfredo Dias Oliveira-Filho, José Augusto Barreto-Filho, Sabrina Joany Felizardo Neves, Divaldo Pereira de Lyra Junior, Association between the 8-item Morisky Medication Adherence Scale (MMAS-8) and blood pressure control. Arquivos Brasileiros De Cardiologia. ,vol. 99, pp. 649- 658 ,(2012) , 10.1590/S0066-782X2012005000053
Guido Grassi, Michele Bombelli, Gino Seravalle, Gianmaria Brambilla, Raffaella Dell’Oro, Giuseppe Mancia, Role of Ambulatory Blood Pressure Monitoring in Resistant Hypertension Current Hypertension Reports. ,vol. 15, pp. 232- 237 ,(2013) , 10.1007/S11906-013-0349-0